PCSK9

1. PCSK9 lowers the risk of cardiovascular disease in humans (HR=0.71, 95%CI: 0.52-0.96).

   Humansfree of CVD in 2014median follow-up of 6.7 yearsmales

   Circulating PCSK9 as a sex-stratified predictor in primary prevention of cardiovascular disease: Insights from a prospective cohort study in Chinese adults · American journal of preventive cardiology · 6 Aug 2026

2. PCSK9 raises the risk of cardiovascular disease in humans (HR=1.38, 95%CI: 1.03-1.84).

   Humansfree of CVD in 2014median follow-up of 6.7 yearsfemales

   Circulating PCSK9 as a sex-stratified predictor in primary prevention of cardiovascular disease: Insights from a prospective cohort study in Chinese adults · American journal of preventive cardiology · 6 Aug 2026

Cardiovascular disease →

1. PCSK9 predicts cancer in humans (AUC=0.726).

   Humansin obese individuals with T2DM10 years

   Circulating PCSK9: A new frontier in cancer risk stratification for obese diabetics · Oncology letters · 11 Sep 2026

Cancer →